Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 65 entries
Sorted by: Best Match Show Resources per page
Determinants of Mammography Screening Participation in Adult Childhood Cancer Survivors: Results From the Childhood Cancer Survivor Study.

Oncology nursing forum

Cox CL, Oeffinger KC, Montgomery M, Hudson MM, Mertens AC, Whitton J, Robison LL.
PMID: 19596651
Oncol Nurs Forum. 2009 May 01;36(3):335-344. doi: 10.1188/09.ONF.335-344.

Purpose/Objectives: To identify treatment, intrapersonal, and provider factors that influence childhood cancer survivors' adherence to recommended mammography screening.Design: Secondary analysis of data derived from three consecutive surveys within the Childhood Cancer Survivor Study.Sample: Female childhood cancer survivors: N =...

Cite
Cox CL, Oeffinger KC, Montgomery M, et al. Determinants of Mammography Screening Participation in Adult Childhood Cancer Survivors: Results From the Childhood Cancer Survivor Study. Oncol Nurs Forum. 2009;36(3):335-344doi: 10.1188/09.ONF.335-344.
Cox, C. L., Oeffinger, K. C., Montgomery, M., Hudson, M. M., Mertens, A. C., Whitton, J., & Robison, L. L. (2009). Determinants of Mammography Screening Participation in Adult Childhood Cancer Survivors: Results From the Childhood Cancer Survivor Study. Oncology nursing forum, 36(3), 335-344. https://doi.org/10.1188/09.ONF.335-344
Cox, Cheryl L, et al. "Determinants of Mammography Screening Participation in Adult Childhood Cancer Survivors: Results From the Childhood Cancer Survivor Study." Oncology nursing forum vol. 36,3 (2009): 335-344. doi: https://doi.org/10.1188/09.ONF.335-344
Cox CL, Oeffinger KC, Montgomery M, Hudson MM, Mertens AC, Whitton J, Robison LL. Determinants of Mammography Screening Participation in Adult Childhood Cancer Survivors: Results From the Childhood Cancer Survivor Study. Oncol Nurs Forum. 2009 May 01;36(3):335-344. doi: 10.1188/09.ONF.335-344. PMID: 19596651; PMCID: PMC2712119.
Copy Download .nbib Format: NLM
Laboratory growth of denitrifying water column microbial consortia from deep-sea shipwrecks in the northern Gulf of Mexico.

F1000Research

Haridas D, Biffinger JC, Boyd TJ, Fulmer PA, Hamdan LJ, Fitzgerald LA.
PMID: 30109018
F1000Res. 2017 Oct 13;6:1834. doi: 10.12688/f1000research.12713.2. eCollection 2017.

No abstract available.

Cite
Haridas D, Biffinger JC, Boyd TJ, et al. Laboratory growth of denitrifying water column microbial consortia from deep-sea shipwrecks in the northern Gulf of Mexico. F1000Res. 2017;6:1834doi: 10.12688/f1000research.12713.2.
Haridas, D., Biffinger, J. C., Boyd, T. J., Fulmer, P. A., Hamdan, L. J., & Fitzgerald, L. A. (2017). Laboratory growth of denitrifying water column microbial consortia from deep-sea shipwrecks in the northern Gulf of Mexico. F1000Research, 61834. https://doi.org/10.12688/f1000research.12713.2
Haridas, Dhanya, et al. "Laboratory growth of denitrifying water column microbial consortia from deep-sea shipwrecks in the northern Gulf of Mexico." F1000Research vol. 6 (2017): 1834. doi: https://doi.org/10.12688/f1000research.12713.2
Haridas D, Biffinger JC, Boyd TJ, Fulmer PA, Hamdan LJ, Fitzgerald LA. Laboratory growth of denitrifying water column microbial consortia from deep-sea shipwrecks in the northern Gulf of Mexico. F1000Res. 2017 Oct 13;6:1834. doi: 10.12688/f1000research.12713.2. eCollection 2017. PMID: 30109018; PMCID: PMC6069730.
Copy Download .nbib Format: NLM
Baseline patient reported outcome measurement information system (PROMIS) scores in children with idiopathic scoliosis and their relation to the SRS-22.

Spine deformity

Bouton D, Fedorak G, Oeffinger DJ, Gupta P, Luhmann S, Stasikelis P, Szczodry M, Talwalkar V, Hung M.
PMID: 34269996
Spine Deform. 2022 Jan;10(1):63-68. doi: 10.1007/s43390-021-00388-2. Epub 2021 Jul 16.

PURPOSE: PROMIS is becoming the most commonly utilized patient-reported outcome measure (PROM) in adult orthopaedics, but its adoption has lagged in pediatrics. Limited baseline data exists in pediatric-specific orthopaedic diagnoses. The objective of this study was to determine baseline...

Cite
Bouton D, Fedorak G, Oeffinger DJ, et al. Baseline patient reported outcome measurement information system (PROMIS) scores in children with idiopathic scoliosis and their relation to the SRS-22. Spine Deform. 2021;10(1):63-68doi: 10.1007/s43390-021-00388-2.
Bouton, D., Fedorak, G., Oeffinger, D. J., Gupta, P., Luhmann, S., Stasikelis, P., Szczodry, M., Talwalkar, V., & Hung, M. (2022). Baseline patient reported outcome measurement information system (PROMIS) scores in children with idiopathic scoliosis and their relation to the SRS-22. Spine deformity, 10(1), 63-68. https://doi.org/10.1007/s43390-021-00388-2
Bouton, Daniel, et al. "Baseline patient reported outcome measurement information system (PROMIS) scores in children with idiopathic scoliosis and their relation to the SRS-22." Spine deformity vol. 10,1 (2022): 63-68. doi: https://doi.org/10.1007/s43390-021-00388-2
Bouton D, Fedorak G, Oeffinger DJ, Gupta P, Luhmann S, Stasikelis P, Szczodry M, Talwalkar V, Hung M. Baseline patient reported outcome measurement information system (PROMIS) scores in children with idiopathic scoliosis and their relation to the SRS-22. Spine Deform. 2022 Jan;10(1):63-68. doi: 10.1007/s43390-021-00388-2. Epub 2021 Jul 16. PMID: 34269996.
Copy Download .nbib Format: NLM
Longitudinal Evaluation of Neuromuscular Dysfunction in Long-term Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Rodwin RL, Chen Y, Yasui Y, Leisenring WM, Gibson TM, Nathan PC, Howell RM, Krull KR, Mohrmann C, Hayashi RJ, Chow EJ, Oeffinger KC, Armstrong GT, Ness KK, Kadan-Lottick NS.
PMID: 34099519
Cancer Epidemiol Biomarkers Prev. 2021 Aug;30(8):1536-1545. doi: 10.1158/1055-9965.EPI-21-0154. Epub 2021 Jun 07.

BACKGROUND: Children treated for cancer are at risk for neuromuscular dysfunction, but data are limited regarding prevalence, longitudinal patterns, and long-term impact.METHODS: Longitudinal surveys from 25,583 childhood cancer survivors ≥5 years from diagnosis and 5,044 siblings from the Childhood...

Cite
Rodwin RL, Chen Y, Yasui Y, et al. Longitudinal Evaluation of Neuromuscular Dysfunction in Long-term Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2021;30(8):1536-1545doi: 10.1158/1055-9965.EPI-21-0154.
Rodwin, R. L., Chen, Y., Yasui, Y., Leisenring, W. M., Gibson, T. M., Nathan, P. C., Howell, R. M., Krull, K. R., Mohrmann, C., Hayashi, R. J., Chow, E. J., Oeffinger, K. C., Armstrong, G. T., Ness, K. K., & Kadan-Lottick, N. S. (2021). Longitudinal Evaluation of Neuromuscular Dysfunction in Long-term Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(8), 1536-1545. https://doi.org/10.1158/1055-9965.EPI-21-0154
Rodwin, Rozalyn L, et al. "Longitudinal Evaluation of Neuromuscular Dysfunction in Long-term Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,8 (2021): 1536-1545. doi: https://doi.org/10.1158/1055-9965.EPI-21-0154
Rodwin RL, Chen Y, Yasui Y, Leisenring WM, Gibson TM, Nathan PC, Howell RM, Krull KR, Mohrmann C, Hayashi RJ, Chow EJ, Oeffinger KC, Armstrong GT, Ness KK, Kadan-Lottick NS. Longitudinal Evaluation of Neuromuscular Dysfunction in Long-term Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2021 Aug;30(8):1536-1545. doi: 10.1158/1055-9965.EPI-21-0154. Epub 2021 Jun 07. PMID: 34099519; PMCID: PMC8523186.
Copy Download .nbib Format: NLM
Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy.

JACC. CardioOncology

Yu AF, Moskowitz CS, Chuy KL, Yang J, Dang CT, Liu JE, Oeffinger KC, Steingart RM.
PMID: 33103123
JACC CardioOncol. 2020 Jun;2(2):166-175. doi: 10.1016/j.jaccao.2020.03.002. Epub 2020 Jun 16.

BACKGROUND: Guidelines recommend left ventricular ejection fraction (LVEF) assessments every 3 months for cardiotoxicity monitoring during human epidermal growth factor receptor 2 (HER2) targeted therapy. Evidence in support of this practice is lacking.OBJECTIVES: This study examines the association between...

Cite
Yu AF, Moskowitz CS, Chuy KL, et al. Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy. JACC CardioOncol. 2020;2(2):166-175doi: 10.1016/j.jaccao.2020.03.002.
Yu, A. F., Moskowitz, C. S., Chuy, K. L., Yang, J., Dang, C. T., Liu, J. E., Oeffinger, K. C., & Steingart, R. M. (2020). Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy. JACC. CardioOncology, 2(2), 166-175. https://doi.org/10.1016/j.jaccao.2020.03.002
Yu, Anthony F, et al. "Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy." JACC. CardioOncology vol. 2,2 (2020): 166-175. doi: https://doi.org/10.1016/j.jaccao.2020.03.002
Yu AF, Moskowitz CS, Chuy KL, Yang J, Dang CT, Liu JE, Oeffinger KC, Steingart RM. Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy. JACC CardioOncol. 2020 Jun;2(2):166-175. doi: 10.1016/j.jaccao.2020.03.002. Epub 2020 Jun 16. PMID: 33103123; PMCID: PMC7584138.
Copy Download .nbib Format: NLM
Innovative Safe Water Program Improvement E-Learning for Environmental Health Professionals.

Journal of environmental health

Sabogal R, Kalis M, Hubbard B, Oeffinger J, Baddour LJ, Tate C, Shorter C.
PMID: 32327767
J Environ Health. 2018 Jun;80(10):38-40.

No abstract available.

Cite
Sabogal R, Kalis M, Hubbard B, et al. Innovative Safe Water Program Improvement E-Learning for Environmental Health Professionals. J Environ Health. 2018;80(10):38-40
Sabogal, R., Kalis, M., Hubbard, B., Oeffinger, J., Baddour, L. J., Tate, C., & Shorter, C. (2018). Innovative Safe Water Program Improvement E-Learning for Environmental Health Professionals. Journal of environmental health, 80(10), 38-40.
Sabogal, Raquel, et al. "Innovative Safe Water Program Improvement E-Learning for Environmental Health Professionals." Journal of environmental health vol. 80,10 (2018): 38-40.
Sabogal R, Kalis M, Hubbard B, Oeffinger J, Baddour LJ, Tate C, Shorter C. Innovative Safe Water Program Improvement E-Learning for Environmental Health Professionals. J Environ Health. 2018 Jun;80(10):38-40. PMID: 32327767; PMCID: PMC7179049.
Copy Download .nbib Format: NLM
Esophageal disease among childhood cancer survivors-A report from the Childhood Cancer Survivors Study.

Pediatric blood & cancer

Asdahl PH, Oeffinger KC, Albieri V, Hudson M, Leisenring WM, Donaldson SS, Hasle H, Winther JF, Armstrong GT, Robison LL.
PMID: 33844445
Pediatr Blood Cancer. 2021 Aug;68(8):e29043. doi: 10.1002/pbc.29043. Epub 2021 Apr 12.

There is limited information addressing the occurrence of esophageal strictures among the growing population of survivors of childhood cancer. Using the Childhood Cancer Survivor Study, we analyzed data from 17,121 5-year survivors and 3400 siblings to determine the prevalence...

Cite
Asdahl PH, Oeffinger KC, Albieri V, et al. Esophageal disease among childhood cancer survivors-A report from the Childhood Cancer Survivors Study. Pediatr Blood Cancer. 2021;68(8):e29043doi: 10.1002/pbc.29043.
Asdahl, P. H., Oeffinger, K. C., Albieri, V., Hudson, M., Leisenring, W. M., Donaldson, S. S., Hasle, H., Winther, J. F., Armstrong, G. T., & Robison, L. L. (2021). Esophageal disease among childhood cancer survivors-A report from the Childhood Cancer Survivors Study. Pediatric blood & cancer, 68(8), e29043. https://doi.org/10.1002/pbc.29043
Asdahl, Peter H, et al. "Esophageal disease among childhood cancer survivors-A report from the Childhood Cancer Survivors Study." Pediatric blood & cancer vol. 68,8 (2021): e29043. doi: https://doi.org/10.1002/pbc.29043
Asdahl PH, Oeffinger KC, Albieri V, Hudson M, Leisenring WM, Donaldson SS, Hasle H, Winther JF, Armstrong GT, Robison LL. Esophageal disease among childhood cancer survivors-A report from the Childhood Cancer Survivors Study. Pediatr Blood Cancer. 2021 Aug;68(8):e29043. doi: 10.1002/pbc.29043. Epub 2021 Apr 12. PMID: 33844445.
Copy Download .nbib Format: NLM
Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Shrestha S, Bates JE, Liu Q, Smith SA, Oeffinger KC, Chow EJ, Gupta AC, Owens CA, Constine LS, Hoppe BS, Leisenring WM, Qiao Y, Weathers RE, Court LE, Pinnix CC, Kry SF, Mulrooney DA, Armstrong GT, Yasui Y, Howell RM.
PMID: 34454975
Radiother Oncol. 2021 Oct;163:199-208. doi: 10.1016/j.radonc.2021.08.012. Epub 2021 Aug 26.

BACKGROUND AND PURPOSE: We previously evaluated late cardiac disease in long-term survivors in the Childhood Cancer Survivor Study (CCSS) based on heart radiation therapy (RT) doses estimated from an age-scaled phantom with a simple atlas-based heart model (HMETHODS: We...

Cite
Shrestha S, Bates JE, Liu Q, et al. Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study. Radiother Oncol. 2021;163:199-208doi: 10.1016/j.radonc.2021.08.012.
Shrestha, S., Bates, J. E., Liu, Q., Smith, S. A., Oeffinger, K. C., Chow, E. J., Gupta, A. C., Owens, C. A., Constine, L. S., Hoppe, B. S., Leisenring, W. M., Qiao, Y., Weathers, R. E., Court, L. E., Pinnix, C. C., Kry, S. F., Mulrooney, D. A., Armstrong, G. T., Yasui, Y., & Howell, R. M. (2021). Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 163199-208. https://doi.org/10.1016/j.radonc.2021.08.012
Shrestha, Suman, et al. "Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 163 (2021): 199-208. doi: https://doi.org/10.1016/j.radonc.2021.08.012
Shrestha S, Bates JE, Liu Q, Smith SA, Oeffinger KC, Chow EJ, Gupta AC, Owens CA, Constine LS, Hoppe BS, Leisenring WM, Qiao Y, Weathers RE, Court LE, Pinnix CC, Kry SF, Mulrooney DA, Armstrong GT, Yasui Y, Howell RM. Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study. Radiother Oncol. 2021 Oct;163:199-208. doi: 10.1016/j.radonc.2021.08.012. Epub 2021 Aug 26. PMID: 34454975.
Copy Download .nbib Format: NLM
Cancer Screening in Primary Care: So Much Progress, So Much Left to Do.

The Medical clinics of North America

Smith RA, Oeffinger KC.
PMID: 33099458
Med Clin North Am. 2020 Nov;104(6):xv-xvii. doi: 10.1016/j.mcna.2020.09.002.

No abstract available.

Cite
Smith RA, Oeffinger KC. Cancer Screening in Primary Care: So Much Progress, So Much Left to Do. Med Clin North Am. 2020;104(6):xv-xviidoi: 10.1016/j.mcna.2020.09.002.
Smith, R. A., & Oeffinger, K. C. (2020). Cancer Screening in Primary Care: So Much Progress, So Much Left to Do. The Medical clinics of North America, 104(6), xv-xvii. https://doi.org/10.1016/j.mcna.2020.09.002
Smith, Robert A, and Oeffinger, Kevin C. "Cancer Screening in Primary Care: So Much Progress, So Much Left to Do." The Medical clinics of North America vol. 104,6 (2020): xv-xvii. doi: https://doi.org/10.1016/j.mcna.2020.09.002
Smith RA, Oeffinger KC. Cancer Screening in Primary Care: So Much Progress, So Much Left to Do. Med Clin North Am. 2020 Nov;104(6):xv-xvii. doi: 10.1016/j.mcna.2020.09.002. PMID: 33099458.
Copy Download .nbib Format: NLM
Cost-Sharing and Out-of-Pocket Cost for Women Who Received MRI for Breast Cancer Screening.

Journal of the National Cancer Institute

Pan IW, Oeffinger KC, Shih YT.
PMID: 34320199
J Natl Cancer Inst. 2021 Jul 28; doi: 10.1093/jnci/djab150. Epub 2021 Jul 28.

BACKGROUND: The financial protection of the Affordable Care Act's (ACA) prevention provision doesn't apply to breast MRI but only to mammography for breast cancer screening. The purpose of the study is to examine the financial burden among women who...

Cite
Pan IW, Oeffinger KC, Shih YT. Cost-Sharing and Out-of-Pocket Cost for Women Who Received MRI for Breast Cancer Screening. J Natl Cancer Inst. 2021;doi: 10.1093/jnci/djab150.
Pan, I. W., Oeffinger, K. C., & Shih, Y. T. (2021). Cost-Sharing and Out-of-Pocket Cost for Women Who Received MRI for Breast Cancer Screening. Journal of the National Cancer Institute, . https://doi.org/10.1093/jnci/djab150
Pan, I-Wen, et al. "Cost-Sharing and Out-of-Pocket Cost for Women Who Received MRI for Breast Cancer Screening." Journal of the National Cancer Institute vol. (2021). doi: https://doi.org/10.1093/jnci/djab150
Pan IW, Oeffinger KC, Shih YT. Cost-Sharing and Out-of-Pocket Cost for Women Who Received MRI for Breast Cancer Screening. J Natl Cancer Inst. 2021 Jul 28; doi: 10.1093/jnci/djab150. Epub 2021 Jul 28. PMID: 34320199.
Copy Download .nbib Format: NLM
Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.

Cancer

Henderson TO, Fowler BW, Hamann HA, Nathan PC, Whitton J, Leisenring WM, Oeffinger KC, Neglia JP, Turcotte LM, Arnold MA, Conces MR, Howell RM, Robison LL, Armstrong GT, Alexander KA.
PMID: 34606625
Cancer. 2022 Jan 15;128(2):373-382. doi: 10.1002/cncr.33922. Epub 2021 Oct 04.

BACKGROUND: Human papillomavirus (HPV)-associated subsequent malignant neoplasms (SMNMETHODS: The cumulative risk of SMNRESULTS: In total, 46 survivors developed an SMNCONCLUSIONS: Childhood cancer survivors are at increased risk for SMN in sites susceptible to HPV-associated malignancies. Further research examining HPV...

Cite
Henderson TO, Fowler BW, Hamann HA, et al. Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor. Cancer. 2021;128(2):373-382doi: 10.1002/cncr.33922.
Henderson, T. O., Fowler, B. W., Hamann, H. A., Nathan, P. C., Whitton, J., Leisenring, W. M., Oeffinger, K. C., Neglia, J. P., Turcotte, L. M., Arnold, M. A., Conces, M. R., Howell, R. M., Robison, L. L., Armstrong, G. T., & Alexander, K. A. (2022). Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor. Cancer, 128(2), 373-382. https://doi.org/10.1002/cncr.33922
Henderson, Tara O, et al. "Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor." Cancer vol. 128,2 (2022): 373-382. doi: https://doi.org/10.1002/cncr.33922
Henderson TO, Fowler BW, Hamann HA, Nathan PC, Whitton J, Leisenring WM, Oeffinger KC, Neglia JP, Turcotte LM, Arnold MA, Conces MR, Howell RM, Robison LL, Armstrong GT, Alexander KA. Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor. Cancer. 2022 Jan 15;128(2):373-382. doi: 10.1002/cncr.33922. Epub 2021 Oct 04. PMID: 34606625; PMCID: PMC8738100.
Copy Download .nbib Format: NLM
Opioid Prescribing and Use Among Cancer Survivors: A Mapping Review of Observational and Intervention Studies.

Journal of pain and symptom management

Check DK, Avecilla RAV, Mills C, Dinan MA, Kamal AH, Murphy B, Rezk S, Winn A, Oeffinger KC.
PMID: 34748896
J Pain Symptom Manage. 2021 Nov 05; doi: 10.1016/j.jpainsymman.2021.10.015. Epub 2021 Nov 05.

CONTEXT: Recent years show a sharp increase in research on opioid use among cancer survivors, but evidence syntheses are lacking, leaving knowledge gaps. Corresponding research needs are unclear.OBJECTIVES: To provide an evidence synthesis.METHODS: We searched PubMed and Embase, identifying...

Cite
Check DK, Avecilla RAV, Mills C, et al. Opioid Prescribing and Use Among Cancer Survivors: A Mapping Review of Observational and Intervention Studies. J Pain Symptom Manage. 2021;doi: 10.1016/j.jpainsymman.2021.10.015.
Check, D. K., Avecilla, R. A. V., Mills, C., Dinan, M. A., Kamal, A. H., Murphy, B., Rezk, S., Winn, A., & Oeffinger, K. C. (2021). Opioid Prescribing and Use Among Cancer Survivors: A Mapping Review of Observational and Intervention Studies. Journal of pain and symptom management, . https://doi.org/10.1016/j.jpainsymman.2021.10.015
Check, Devon K, et al. "Opioid Prescribing and Use Among Cancer Survivors: A Mapping Review of Observational and Intervention Studies." Journal of pain and symptom management vol. (2021). doi: https://doi.org/10.1016/j.jpainsymman.2021.10.015
Check DK, Avecilla RAV, Mills C, Dinan MA, Kamal AH, Murphy B, Rezk S, Winn A, Oeffinger KC. Opioid Prescribing and Use Among Cancer Survivors: A Mapping Review of Observational and Intervention Studies. J Pain Symptom Manage. 2021 Nov 05; doi: 10.1016/j.jpainsymman.2021.10.015. Epub 2021 Nov 05. PMID: 34748896.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 65 entries